Article
Phase II Drug-Metabolizing Polymorphisms and Smoking Predict Recurrence of Non-Muscle-Invasive Bladder Cancer: A Gene-Smoking Interaction.
Cancer prevention research (Philadelphia, Pa.) - 1 Feb 2016
Lacombe Louis, Fradet Vincent, Lévesque Éric, Pouliot Frédéric, Larue Hélène, Bergeron Alain, Hovington Hélène, Caron André, Nguile-Makao Molière, Harvey Mario, Fradet Yves, Guillemette Chantal
Abstract excerpt
Cigarette smoking is the most important known risk factor for urinary bladder cancer. Selected arylamines in cigarette smoke are recognized human bladder carcinogens and undergo biotransformation through several detoxification pathways, such as the glutathione S-transferases (GST), and uridine-diphospho-glucuronosyltransferases (UGT) pathways. GSTM1 deletion status and UGT1A1*28 rs8175347 genotypes were assessed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
